Market Exclusive

Analyst Activity – Morgan Stanley Lowers Its Price Target On NASDAQ:AMGN – Amgen (NASDAQ:AMGN) to $200.00

Analyst Ratings For NASDAQ:AMGN – Amgen (NASDAQ:AMGN)

Today, Morgan Stanley lowered its price target on NASDAQ:AMGN – Amgen (NASDAQ:AMGN) to $200.00 per share.

Some recent analyst ratings include

Dividend information for NASDAQ:AMGN – Amgen (NASDAQ:AMGN)

NASDAQ:AMGN – Amgen (NASDAQ:AMGN) pays an annual dividend of $5.28 with a yield of 3.07% and an average dividend growth of 23.50% based on a 3 Year Average..

Dividend History for NASDAQ:AMGN – Amgen (NASDAQ:AMGN)

Recent Insider Trading Activity For NASDAQ:AMGN – Amgen (NASDAQ:AMGN)
NASDAQ:AMGN – Amgen (NASDAQ:AMGN) has insider ownership of 0.27% and institutional ownership of 85.76%.

Recent Trading Activity for NASDAQ:AMGN – Amgen (NASDAQ:AMGN)
Shares of NASDAQ:AMGN – Amgen closed the previous trading session at 171.59 down -0.35 0.20% with shares trading hands.

Exit mobile version